Division of Cardiovascular Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Eur Heart J. 2011 Aug;32(16):2075-84. doi: 10.1093/eurheartj/ehq475. Epub 2010 Dec 31.
Ultrasound-targeted microbubble destruction (UTMD) uses ultrasound energy to selectively deliver genes into the myocardium using plasmids conjugated to microbubbles. We hypothesized that repeated delivery of stem cell-mobilizing genes could boost the ability of this therapy to enhance cardiac repair and ventricular function after a myocardial infarction.
Beginning 7 days after coronary artery ligation, stem cell factor (SCF) and stromal cell-derived factor (SDF)-1α genes were administered to adult rats using 1, 3, or 6 UTMD treatments (repeat 1, 3, and 6 groups) at 2-day intervals (control=6 treatments with empty plasmid). Cardiac function (echocardiography) and myocardial perfusion (myocardial contrast echocardiography) were assessed on Days -7, 0, and 24 relative to the first treatment. Histological and biochemical assessments were performed on Day 24. Multiple UTMD treatments were associated with an increased presence of myocardial SCF and SDF-1α proteins and their receptors (vs. control and Repeat 1). All UTMD recipients exhibited increased vascular densities and smaller infarct regions (vs. control), with the highest ventricular densities in response to multiple treatments. Myocardial perfusion and ventricular function at Day 24 also improved progressively (vs. control) with the number of UTMD treatments.
Targeted ultrasound delivery of SCF and SDF-1α genes to the infarcted myocardium recruited progenitor cells and increased vascular density. Multiple UTMD treatments enhanced tissue repair, perfusion, and cardiac function. Repeated UTMD therapy may be applied to tailor the number of interventions required to optimize cardiac regeneration after an infarction.
超声靶向微泡破坏(UTMD)利用超声能量将与微泡结合的质粒选择性地递送到心肌中。我们假设,重复递送干细胞动员基因可以增强这种治疗方法在心肌梗死后增强心脏修复和心室功能的能力。
在冠状动脉结扎后 7 天开始,使用 1、3 或 6 次 UTMD 治疗(重复 1、3 和 6 组),每隔 2 天(对照组用空质粒进行 6 次治疗),向成年大鼠给予干细胞因子(SCF)和基质细胞衍生因子(SDF-1α)基因。在第一次治疗前的第-7、0 和 24 天,评估心脏功能(超声心动图)和心肌灌注(心肌对比超声心动图)。在第 24 天进行组织学和生化评估。与对照组和重复 1 组相比,多次 UTMD 治疗与心肌中 SCF 和 SDF-1α 蛋白及其受体的存在增加有关。所有 UTMD 受者均表现出血管密度增加和梗死区缩小(与对照组相比),而对多次治疗的反应则表现出最高的心室密度。在第 24 天,心肌灌注和心室功能也随着 UTMD 治疗次数的增加而逐渐改善(与对照组相比)。
将 SCF 和 SDF-1α 基因靶向超声递送到梗死心肌中可招募祖细胞并增加血管密度。多次 UTMD 治疗可增强组织修复、灌注和心脏功能。重复 UTMD 治疗可用于调整干预次数,以优化心肌梗死后的心脏再生。